Search - tctmd.com

Displaying 201 - 220 of 1798

Sort: Relevancy | Date

Presentation TCT 2023

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

Presenter: Hyunki LEE

October 25, 2023

Presentation TCT 2023

TCT 381: The Clinical implementation of CYP2C19 genotyping in patients with an acute coronary syndrome: Insights from the FORCE-ACS registry

Presenter: Jaouad Azzahhafi

October 25, 2023

Presentation TCT 2023

TCT 135: Ticagrelor Coated Stent to Eliminate the Need for DAPT post-PCI

Presenter: Jared Romeo

October 25, 2023

Presentation TCT 2023

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

Presenter: Taehoon Kim

October 25, 2023

Presentation TCT 2023

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

Presenter: Sang Hyun Kim

October 25, 2023

Presentation TCT 2023

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

Presenter: Hyunki LEE

October 25, 2023

Presentation TCT 2023

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

Presenter: Eva Woelders

October 25, 2023

Presentation TCT 2023

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

Presenter: Cole Clifford

October 25, 2023

Presentation TCT 2023

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

Presenter: Minju Han

October 25, 2023

Presentation TCT 2023

TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis.

Presenter: Purveshkumar Patel

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography

Presenter: Ting-Yu Wang

October 25, 2023

Presentation TCT 2023

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

Presenter: Seong Huan Choi

October 25, 2023

Presentation TCT 2023

TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention

Presenter: Ji-Yeon Kim

October 25, 2023

Presentation TCT 2023

Long Term Maintenance Antiplatelet Therapy After PCI

Presenter: Hyo-Soo Kim

October 24, 2023

Presentation TCT 2023

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

Presenter: Jacqueline Tamis-Holland

October 24, 2023

Presentation TCT 2023

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Presenter: Sripal Bangalore

October 24, 2023

Presentation TCT 2023

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Presenter: Harold Dauerman

October 24, 2023

Presentation TCT 2023

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Presenter: Dominick Angiolillo

October 24, 2023

News Conference News EACTS 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Michael O'Riordan

October 13, 2023

Advertisement

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

TCT 381: The Clinical implementation of CYP2C19 genotyping in patients with an acute coronary syndrome: Insights from the FORCE-ACS registry

TCT 135: Ticagrelor Coated Stent to Eliminate the Need for DAPT post-PCI

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis.

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention

Long Term Maintenance Antiplatelet Therapy After PCI

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content